United Therapeutics Corp (UTHR)
237.00
+2.53
(+1.08%)
USD |
NASDAQ |
Apr 24, 16:00
237.18
+0.18
(+0.08%)
After-Hours: 20:00
United Therapeutics Free Cash Flow (Quarterly): 72.00M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 72.00M |
| September 30, 2023 | 280.50M |
| June 30, 2023 | 61.60M |
| March 31, 2023 | 333.50M |
| December 31, 2022 | 88.70M |
| September 30, 2022 | 189.80M |
| June 30, 2022 | 110.00M |
| March 31, 2022 | 275.20M |
| December 31, 2021 | 104.00M |
| September 30, 2021 | 162.30M |
| June 30, 2021 | 131.90M |
| March 31, 2021 | 79.20M |
| December 31, 2020 | 113.90M |
| September 30, 2020 | 235.10M |
| June 30, 2020 | 145.80M |
| March 31, 2020 | 201.60M |
| December 31, 2019 | 77.80M |
| September 30, 2019 | 171.80M |
| June 30, 2019 | 112.60M |
| March 31, 2019 | -652.50M |
| December 31, 2018 | 33.60M |
| September 30, 2018 | 196.00M |
| June 30, 2018 | 126.30M |
| March 31, 2018 | 238.10M |
| December 31, 2017 | -113.60M |
| Date | Value |
|---|---|
| September 30, 2017 | 236.50M |
| June 30, 2017 | 49.80M |
| March 31, 2017 | 215.20M |
| December 31, 2016 | 153.90M |
| September 30, 2016 | 219.60M |
| June 30, 2016 | 115.30M |
| March 31, 2016 | 116.80M |
| December 31, 2015 | -6.00M |
| September 30, 2015 | 196.70M |
| June 30, 2015 | 37.20M |
| March 31, 2015 | 105.10M |
| December 31, 2014 | 88.40M |
| September 30, 2014 | 194.89M |
| June 30, 2014 | -67.32M |
| March 31, 2014 | 91.92M |
| December 31, 2013 | 91.01M |
| September 30, 2013 | 129.88M |
| June 30, 2013 | 79.01M |
| March 31, 2013 | 93.46M |
| December 31, 2012 | 83.95M |
| September 30, 2012 | 86.72M |
| June 30, 2012 | 43.75M |
| March 31, 2012 | -2.697M |
| December 31, 2011 | 52.38M |
| September 30, 2011 | 62.84M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
61.60M
Minimum
Jun 2023
333.50M
Maximum
Mar 2023
155.12M
Average
131.90M
Median
Jun 2021
Free Cash Flow (Quarterly) Benchmarks
| Liquidia Corp | -16.19M |
| Esperion Therapeutics Inc | -37.06M |
| Vertex Pharmaceuticals Inc | 118.50M |
| Heron Therapeutics Inc | 2.205M |
| Aldeyra Therapeutics Inc | 0.5004M |